Guangyan Si

Guangyan Si

Auto-generated profile, based on publicly available information

Guangyan Si

Department of Interventional Radiology, the Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University, Luzhou, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
ZLZhaonan Li
Zhaonan Li
DJDechao Jiao
Dechao Jiao
XHXinwei Han
Xinwei Han
GSGuangyan Si
Guangyan Si
YLYahua Li
Yahua Li
XZXun Zhang
Xun Zhang
Purpose: To evaluate the method and effectiveness of transcatheter arterial chemoembolization (TACE) combined with simultaneous DynaCT-guided Microwave ablation (MWA) for the treatment of small hepatocellular carcinoma (SHCC). Materials and methods: From June 2015 to May 2017, a total of 28 consecutive patients with SHCC received single treatment of TACE and 23 subjects received a combination treatment of TACE with simultaneous DynaCT-guided MWA. Following 1 month of treatment, the tumor response was assessed using the mRECIST criteria and the outcomes were analyzed including intervention-associated complications, changes in liver function, imaging response, and progression-free survival (PFS). Results: The technical success rate was 100%. The rates of CR (65%) in the combined TACE and MWA group were higher than those of the TACE group (46%). The rate of common adverse events, such as liver abscess, spontaneous bacterial peritonitis and liver dysfunction, in the combined TACE and MWA group (56%) was comparable to the corresponding rate of the TACE group (P > 0.411). The median and mean PFS of the TACE group were significantly lower than those of the combined TACE and MWA group (19.00 months vs. 29.00 months, 21.076 months vs. 24.693 months, p = 0.019, log-rank test). Conclusion: Stereotactic DynaCT-guided MWA is a safe and effective method for the treatment of SHCC, which usually provides an effective tumor puncture path, notably for lesions that cannot be detected following TACE. Overall, the data suggested that this treatment method could improve the clinical outcome of patients with SHCC.

22 November 2019 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
ZLZhaonan Li
Zhaonan Li
DJDe-Chao Jiao
De-Chao Jiao
GSGuangyan Si
Guangyan Si
XHXinwei Han
Xinwei Han
WZWenguang Zhang
Wenguang Zhang
JCJianjian Chen
Jianjian Chen